IL-5 is a key regulator of eosinophilic inflammation and is selectively expressed by antigen-activated T h 2 lymphocytes. An important role for the proximal AP-1 and GATA sites in regulating IL-5 transcription is generally accepted but the significance of an adjacent Ets/NFAT site has remained unclear. We have investigated its role using the mouse T h 2 clone D10.G4.1. Transcription of IL-5 reporter gene plasmids could be induced in D10 cells by phorbol myristate acetate/cyclic adenosine monophosphate (PMA/cAMP) stimulation and significantly further enhanced by activation of the mitogen-activated protein (MAP) kinase pathways. Strong induction of IL-5 mRNA was also induced by PMA/cAMP. Mutagenesis showed that the Ets/NFAT site is of critical importance along with the AP-1 and GATA sites in regulating IL-5 transcription stimulated by PMA/cAMP and MAP kinase activation. Transactivation was used to investigate the transcription factors which could function at the three sites and possible synergistic interactions. AP-1 (c-Fos/c-Jun) strongly induced IL-5 transcription and dominant negative AP-1 constructs confirmed that AP-1 plays an important role in regulating IL-5 expression. Ets1, unlike other members of the Ets/NFAT family, synergized strongly with AP-1 suggesting that Ets1 is the family member which functions at the Ets/NFAT site. AP-1/Ets1 transactivation also stimulated IL-5 mRNA expression. Ets1 binding to the proximal promoter region, demonstrated by chromatin immunoprecipitation, was stimulated by PMA/cAMP. The absolute dependence on the binding sites for Ets1, AP-1 and GATA-3 together with the strong synergy between Ets1 and AP-1 suggest close cooperative interactions between the three transcription factors in the regulation of IL-5 expression in mouse T cells.
Introduction IL-5 is one of the key cytokines produced by activated T lymphocytes that are involved in the regulation of immune and inflammatory responses. IL-5 appears to play a central role in the regulation of eosinophilia and contributes to several human diseases, including asthma (1) (2) (3) (4) . Understanding the regulation of this inducible cytokine may ultimately be valuable in treating various pathological conditions in humans involving eosinophilia. IL-5 is primarily produced by antigen-activated T lymphocytes of the T h 2 subclass and is not produced by T h 1 cells. Many of the studies to date of the IL-5 expression have been carried out using leukemias which do not show the cytokine expression characteristics of T h 2 lymphocytes and therefore may have somewhat different regulatory mechanisms. In the present work, we have used the T h 2 T cell clone D10.G4.1 to study the mechanisms of IL-5 expression in T cells and particularly the role of the Ets/NFAT site in the proximal promoter region.
Activation of T cells requires interaction of the TCR complex with antigens in association with the MHC and results in activation of protein kinase C (PKC) and an increase in intracellular calcium (5) . A second co-stimulatory signal, which can be generated through the CD28 signaling pathway (6) , is provided by antigen-presenting cells (7) . Although T cell activation is usually mimicked in vitro by stimulation with phorbol myristate acetate (PMA) and ionomycin, IL-5 expression in mouse Tcells is optimally stimulated by the combination of PMA and cyclic adenosine monophosphate (cAMP) (8, 9) , consistent with a requirement for activation of PKC (stimulated by PMA) and activation of protein kinase K (PKA) (stimulated by cAMP) for optimal gene induction (10) .
MAP kinase pathways are known to play a critical role in the activation of T cells during the immune response. Three parallel MAP kinase signal transduction pathways have been identified in mammalian cells. These are the extracellular signal-related kinase (ERK; 11), c-Jun N-terminal kinase (JNK; 12) and p38 MAP kinase (13, 14) . The ERK pathway is involved in the positive selection of T cells in the thymus and in T cell activation (15, 16) . JNK is also activated during T cell activation, and appears to integrate signals initiated at the TCR complex and the co-stimulatory molecule CD28 (17) . TCR ligation or PMA treatment is sufficient to maximally induce ERK activity, whereas JNK and p38 activation requires a costimulatory signal such as CD28 ligand binding or ionomycin treatment, respectively (17) (18) (19) .
Inhibition of IL-5 expression by the inhibitor SB203580 has been reported for human T cells (20) and for the mouse T cell clone D10.G4.1 (21) , suggesting a role for p38 MAP kinase in IL-5 gene regulation. Similarly, inhibition by PD98059 suggests involvement of the ERK pathway in IL-5 expression in mouse T cells (22) . Potentially, MAP kinase activation could influence IL-5 expression by increasing the levels and/or activation of AP-1 (23) and GATA-3 (21) as both transcription factors are implicated in regulating IL-5 expression.
A number of studies have been carried out on the transcriptional elements controlling mouse IL-5 expression. Evidence has been obtained supporting a key role for elements in the proximal promoter region in the induction of IL-5 transcription. Conserved lymphokine element 0 (CLE0) (24) is located at ÿ53 to ÿ39 in the mouse IL-5 promoter. It has been shown to be critical for IL-5 expression in EL-4 cells (25, 26) and in D10 cells (27) , although Stranick et al., (28) found CLE0 not to be essential for IL-5 expression in antigenstimulated D10 cells. CLE0 consists of adjacent putative AP-1 and Ets/NFAT binding sites. The major inducible proteins binding to the AP-1 region of mouse IL-5 CLE0 have been reported to be JunB and JunD in D10 cells (29) , c-Fos, JunB and JunD in EL-4 cells (30) and c-Fos, JunB and NFAT in EL-4 cells (31) . No binding to the Ets/NFAT site has been demonstrated in mouse T cell lines and it has not been clear whether this site is critical and whether an Ets or NFAT family member functions at this site. A recent study using human IL-5 promoter constructs in Jurkat cells (32) supports the possibility that a member of the Ets family may be involved in IL-5 gene regulation although further studies are desirable since Jurkat cells do not express IL-5 either constitutively or after stimulation. It has also been reported that the 59 end of the CLE0 element carries an Oct site which overlaps with the AP-1 site (33) . However, recent work on human IL-5 transcription indicates that IL-5 expression can occur in the absence of Oct-2 (34) .
There are several reports suggesting the importance of a GATA site (ÿ71 to ÿ66) located upstream of the CLE0 element in regulating IL-5 expression. These include studies in EL-4 cells (25, 30) and in D10.G4.1 (29, 35, 36) . Siegel et al., (30) and Zhang et al., (29) showed that GATA-3 rather than GATA-4 bound to the GATA element. GATA-3 has been shown to be specifically expressed in T h 2 cells and to be important in the expression of T h 2-specific cytokines (37, 38, 57) . In contrast to these findings, selectivity for GATA-4 has been reported for constitutive human IL-5 expression by the ATL-16T cell line (39, 40) leaving some uncertainty as to which GATA factor functions in IL-5 regulation.
In the present work, studies were carried out in the mouse T h 2 clone D10.G4.1 to investigate the significance of the proximal Ets/NFAT site and to investigate possible synergistic interactions between Ets/NFAT family members and AP-1 and GATA-3. Evidence was obtained that the Ets/NFAT site is of equal importance to the adjacent AP-1 and GATA sites and that each of the three sites is required for IL-5 expression induced by a variety of T cell activation signals. The results also suggest that during T cell stimulation, elevation of AP-1 levels may be important in stimulating IL-5 expression and that Ets1 can strongly synergize with AP-1.
Methods

Cell culture
A subline of mouse T h 2-type D10.G4.1 cells was used in these studies and was maintained in RPMI-1640 medium with the following additives: 10% FCS, 10 mM NaCl, 1 mM sodium pyruvate, 56.2 mM monothioglycerol, 60 lg ml ÿ1 benzylpenicillin, 100 lg ml ÿ1 streptomycin, 2 mM L-glutamine, 0.05 mM b-mercaptoethanol and 25 units ml of IL-2. The IL-2 was prepared from Sf9 cells infected with a baculovirus expressing mouse IL-2 (26). The medium was changed every three days.
Plasmid construction
The ÿ1170mIL5Luc reporter construct contains~1170 bp of sequence preceding the transcription initiation site of the mouse IL-5 promoter. A SacI fragment from ÿ1170SynCATmIL5 construct which encompasses the ÿ1174 to +26 of the 59-unstranslated region of the mouse IL-5 gene was cloned into the SacI site of the pXPG luciferase reporter construct (41) . The mutations of AP-1, Ets/NFATand GATA binding sites of IL-5 promoter were made in this construct using QuickChange TM site-directed mutagenesis system (Stratagene). The ÿ88mIL5Luc construct which carries the proximal 88 bp of the mIL-5 promoter was generated by PCR (forward 59-CCTTTATTAGGTGTCCTCTATC-39, reverse 59-AAGGAAA-CGACTTCCGGTCGCGA-39). Addition of a BamHI site on the sense primer and a KpnI site on the anti-sense primer allowed the fragment to be subcloned into the pXPG luciferase reporter plasmid. The constructs were verified by sequencing.
To construct the GATA-3 expression plasmid, a 2056-bp cDNA encoding GATA-3 was released by EcoRI from pGMmc5bB (42) . This fragment was cloned into the EcoRI site of pEFIRES-P plasmid (43) under the control of the EF-1a promoter. The GATA-4 expression plasmid was similarly constructed using a 1799-bp EcoRI fragment encoding GATA-4 from pMT2mGATA-4 (44) . The c-Jun, c-Fos, Ets1 and Elf1 expression constructs in the pEFBOS expression vector under the control of the EF-1a promoter were described previously (45) (a gift from I. Kola). The other constructs used have been described elsewhere: NFATp and NFATc expression plasmids, (46) dominant negative c-Jun (A-Jun) and c-Fos (A-Fos), (47, 48) and MAP kinase expression constructs Raf-BXB-CX, MLK3 and MKK6E, (19) (provided by U. R. Rapp).
Optimization of transfection efficiency
An expression plasmid containing the gene encoding green fluorescent protein (GFP) was used to optimize transfection efficiency in D10 cells. A total of 5 3 10 6 cells were mixed with 5 lg of GFP plasmid in 300 ll of RPMI-1640 supplemented with 20% FCS in electroporation cuvettes for 15 min at room temperature and subjected to voltage pulses ranging from 230 to 310 V at 975 lF capacitance in a GenePulser apparatus (Bio-Rad). Transfected cells were cultured in 5 ml of complete RPMI-1640 medium for 20 h. One millilitre of cells were transferred into FACS analysis tubes and stained with propidium iodide at 10 lg ml ÿ1 for 30 min and then subjected to FACS assay. The highest level of viable cells expressing GFP was obtained with 270 V and 975 lF capacitance.
Transfection assay D10 cells were grown in RPMI-1640 complete medium and subcultured at 5 3 10 5 cells ml ÿ1 the day before transfection. The cells were harvested and re-suspended in the same medium. A total of 5 310 6 cells were incubated with 20 lg of DNA (5 lg of IL-5 reporter plasmids, 5 lg of different expression plasmid and empty plasmid to make up to 20 lg of total DNA) in 300 ll of growth medium supplemented with 20% FCS for 15 min at room temperature, and subjected to electroporation at 270 V and 975 lF capacitance using GenePulser (Bio-Rad). The cells were transfered into 5 ml of fresh medium and incubated at 37°C for 20 h. Transfected cells were treated with or without PMA and dibutyryl cAMP (cAMP) for 9 h (25 ng ml ÿ1 PMA and 1 mM cAMP). For transactivation effects on endogenous IL-5 mRNA expression, D10 cells were co-transfected with plasmid containing relevant transcription factors (AP-1 and Ets1) and GFP construct at 5 : 1 ratio. After 20 h recovery, transfected cells were sorted by FACS for GFP-positive cells. Expression of IL-5 mRNA was analyzed by real-time PCR.
Luciferase assays
After 9 h stimulation, the cells were harvested by centrifugation, washed twice with PBS and then lysed with three rounds of freeze-thaw lysis in liquid nitrogen in a lysis buffer containing 10 mM K 2 HPO 4 , 1 mM EDTA and 0.2 mM dithiothreitol (DTT). The debris was removed by centrifugation. Protein concentrations of lysates were determined using Bradford protein assay (Bio-Rad). In the luciferase assays, 15 lg of protein extracts were dispensed into 96-well plates and mixed with 200 ll of assay buffer containing 100 mM potassium phosphate buffer (4 parts 100 mM K 2 HPO 4 : 1 part 100 mM KH 2 PO 4 ), 8 mM MgSO 4 , 2 mM DTT, 0.75 mM ATP and 0.175 mM co-enzyme A. The reactions were initiated by adding 40 ll of 1 mM D-luciferin. The light signal was measured using a TopCounter (Packard). The linearity of the assay was confirmed for high activity samples by measuring the activity of 2-fold dilutions of the protein samples. The background of assay was very low and taken away from all values. Mean and standard derivations of at least three independent experiments are shown in the figures.
Real-time PCR analysis
Total RNA was prepared from stimulated and unstimulated T cells using TriReagent (Sigma-Aldrich) according to manufacturer's instructions. RNA was treated with DNase I and reverse transcribed using Superscript II reverse transcriptase (Invitrogen) as detailed in the manufacturer's instructions. SYBR Green real-time PCRs were performed with 50 ng of cDNA in a total volume of 25 ll on an ABI 7500 sequence detector (Applied Biosystems) with primer for the IL-5 cDNA (forward 59-AGCACAGTGGTGAAAGAGACCTT-39, reverse 59-TCCAATGCATAGCTGGTGATTT-39). The Ct values for IL-5 were normalized to the housekeeper gene ubiquitin-conjugating enzyme E2D.
The following PCR conditions were used: stage1, 50°C for 2 min for one cycle; stage 2, 95°C for 10 min for one cycle and stage 3, 95°C for 15 s and 60°C for 1 min for 40 cycles. Since PCR amplification was monitored by SYBR green, the absence of non-specific amplification was determined by analyzing the dissociation curve of the PCR amplification products.
Chromatin immunoprecipitation analysis
Chromatin immunoprecipitation (ChIP) analysis was performed using a ChIP assay kit from Upstate Biotechnology according to the manufacturer's instructions with slight modifications. In brief, 2 3 10 7 D10 T cells were treated with formaldehyde (1%) for 15 min and the reaction was terminated by the addition of 0.25 M glycine. Cells were washed twice with PBS and re-suspended in SDS lysis buffer (Upstate Biotechnology) and sonicated to shear chromatin. The samples were pre-cleared with 80 ll of salmon sperm DNA-protein A Agarose (Upstate Biotechnology) following by addition of Ets1 antibody (Santa Cruz Biotechnology) or without antibody as a control, overnight with rotation at 4°C. After wash with lowsalt buffer, high-salt buffer, LiCl wash buffer and Tris-EDTA buffer (Upstate Biotechnology), the cross-link between DNA and protein was reversed at 65°C overnight. Samples were recovered by phenol-chloroform extraction and re-suspended in MilliQ water for real-time PCR analysis. Using the conditions described above, SYBR Green real-time PCRs were performed with IL-5setA primer flanking Ets binding site of the IL-5 proximal promoter region (forward 59-ACCCTGAGTTT-CAGGACTCG-39, reverse 59-TCCCCAAGCAATTTATTCTCTC-39) and IL-5setB primer located at ÿ3-kb region of the IL-5 promoter as a control (forward 59-ATAGGCGTTAGGCAC-CATGT-39, reverse 59-TGGGGTGCATGATGTGAA-39). The amount of precipitated target sequence was determined by normalization with the total input.
Western blot analysis
Nuclear extracts were prepared according to the method by Schreiber et al. (49) . Protein concentrations were determined by the Bradford assay (Bio-Rad). Proteins (15 lg) were resolved by SDS-PAGE, transferred to nitrocellulose and subjected to western blot analysis using anti-Ets1 antibody (Santa Cruz Biotechnology). Chemiluminescence was detected using ECL reagents (Amersham Biosciences) according to the manufacturer's instructions.
Electrophoretic mobility shift assays
Recombinant c-Jun and c-Fos (50) (a gift from D. Tremethick) and recombinant Ets1 (45) (supplied by I. Kola) were prepared as previously described. Double-stranded oligonucleotides were end labeled with [c-32p]dATP by T4 polynucleotide kinase (51) . The 15 ng of recombinant proteins (AP-1 and Ets1) and 0.1 ng radiolabeled oligonucleotides were added to the binding buffer containing 1 lg of poly (dI.dC), 25 mM HEPES, 25 mM NaCl, 10% glycerol, 1 mM EDTA, 1 mM DTT and 0.25% Nonidet P-40 in a final volume of 25 ll. Protein-DNA complex was resolved on a 4.5% non-denaturing polyacrylamide gel containing 0.53 TBE (0.5 mM Tris, 42 mM boric acid, 1 mM EDTA, pH 8.3). The gels were dried and exposed to X-ray film (Kodak) at room temperature overnight. In competition experiments, 100-fold excess of unlabeled oligonucleotides which correspond to the same binding site or other unrelated binding sequences were added to the reactions.
Results
Reporter gene assay for IL-5 expression in D10 cells
A transient transfection system was established using a derivative of the mouse T h 2 clone D10.G4.1 to facilitate studies of the transcriptional elements involved in IL-5 gene induction and for transactivation experiments. Optimum conditions for electroporation were obtained with 270 V and 975 lF capacitance in which 27% of transfected cells expressed GFP. Using these conditions, transient transfection of a luciferase reporter construct (ÿ1170mIL5Luc) carrying 1170 bases of the upstream region of the mouse IL-5 gene into D10 cells, and subsequent stimulation of the cells with PMA and dibutyryl cAMP (cAMP) gave significant induction of luciferase expression. It was found that maximal stimulation was achieved after 9-12 h (data not shown). Using optimal conditions for electroporation and stimulation, 36-fold induction of luciferase expression was achieved with PMA/cAMP (Fig. 1B) . PMA alone gave little stimulation, whereas the stimulation with cAMP alone was 10-fold. In addition to induction of luciferase, strong induction of IL-5 mRNA by PMA/cAMP was shown by realtime PCR (Fig. 1C) . The synergistic activation of IL-5 expression by PMA and cAMP in D10 cells is in agreement with our previous studies (26, 52) .
Effect of MAP kinase activation
As MAP kinases are known to play a critical role in the activation of T cells during immune responses, we tested the effect of specific stimulation of the individual MAP kinase pathways on IL-5 transcription. The approach used expression plasmids encoding constitutively active versions of the corresponding upstream kinases (19) . The constructs used were a constitutively active kinase mutant of Raf (Raf-BXB-CX) which serves as a specific ERK activator; MLK3, which when over-expressed results in a strong activation of JNK without affecting ERK and p38 MAP kinase activities and an activated mutant of MKK6 (MKK6E) which serves as a specific activator of p38 (19) .
The ÿ1170mIL5Luc construct was co-transfected with each of the MAP-kinase-stimulating expression constructs into D10 cells. Expression of activated Raf gave 6-fold induction of IL-5 promoter activity, MLK3 gave 2-fold induction but MKK6E had no effect (Fig. 2A) . The stimulation of all three MAP kinase pathways simultaneously gave 9-fold induction ( Fig. 2A) . In contrast to these relatively small effects, activation of each MAP kinase pathway in D10 cells gave strong synergistic stimulation with PMA/cAMP (Fig. 2B) . The stimulations achieved with MKK6E, Raf and MLK3 were, respectively, 34-fold, 27-fold and 21-fold the additive levels obtained with cells stimulated with PMA/cAMP or constitutively active MAP kinase expression construct alone. Thus, activation of each MAP kinase pathway can strongly enhance IL-5 expression in cells stimulated with PMA/cAMP. T cell expression of TNFa is similar in that it is also induced by activation of each MAP kinase pathway (53) .
Mutation of the transcription factor binding sites in the proximal promoter region
The reporter construct used in the experiments described above had 1170 bases of upstream sequence to try and ensure that any relevant upstream regulatory sites were included. However, for stimulation of IL-5 expression by PMA/ cAMP, it was shown that a truncated construct (ÿ88mIL5Luc), carrying just the proximal promoter region of the gene (Fig. 1B) , gave similar levels of induction to the ÿ1170mIL5Luc and exhibited a similar pattern as ÿ1170mIL5Luc in response to different stimuli (data not shown). This construct was also very strongly stimulated by MAP kinase activation (Fig. 3) , indicating that the major positive control elements involved in the stimulations observed were in the proximal promoter region. Within the proximal promoter region there are three putative transcription factor binding sites: Ets/NFAT (ÿ41 to ÿ47), AP-1 (ÿ48 to ÿ54) and GATA (ÿ67 to ÿ72) (Fig. 1A) . Although the importance of the AP-1 and GATA sites are reasonably well accepted, we wished to determine the relative importance of the Ets/NFAT site in comparison to these sites. Mutation of the Ets/NFAT site abolished inducible expression of the ÿ1170mIL5Luc expression construct (Fig. 1B) as did mutation of the other two sites indicating a critical role for each site in gene expression induced by PMA/cAMP. To determine whether the stimulation of IL-5 expression mediated by activation of the MAP kinase pathways was also dependent on the Ets/NFAT, AP-1 and GATA elements, wild-type and mutant ÿ1170mIL5Luc constructs were transfected together with expression vectors for Raf-BXB-CX, MLK3 or MKK6E into D10 cells. Mutation of each of the three transcription factor binding sites greatly reduced the induction of IL-5 expression mediated by activation of each MAP kinase pathway together with PMA/ cAMP stimulation (Fig. 3) .
Investigation of the transcription factors active at the AP-1, Ets/NFAT and GATA sites by transactivation
Transactivation experiments were carried out using expression constructs encoding relevant transcription factors to identify those that could stimulate expression of the IL-5 gene and to test for synergistic interactions. The transcription factors used were c-Fos and c-Jun (AP-1 site) Ets1, Elf1, NFATp or NFATc (Ets/NFAT site) and GATA-3 or GATA-4 (GATA site). Expression constructs for these transcription factors were transiently co-transfected together with the ÿ1170mIL5Luc reporter construct and expression was measured with and without stimulation by PMA/cAMP. AP-1 (c-Fos/c-Jun) gave dramatic transactivation of 400-fold over normal unstimulated levels of expression (Fig. 4A) , indicating that IL-5 gene induction can be achieved by raising the levels of AP-1, without the need for stimulation. Transactivation by Ets, NFAT and GATA family members gave much smaller increases in expression of up to 4-fold in the absence of stimulation. The effect of stimulation by PMA/cAMP on the level of transactivation achieved was also tested. For AP-1, the values after transactivation and stimulation were 250-fold higher than with ÿ1170mIL5Luc alone (Fig. 4B) . Transactivation by Ets1, Elf1, NFATp and NFATc was also tested following stimulation with PMA/cAMP. Elf1 and NFATp gave lower levels of transactivation than Ets1 and NFATc which gave levels of transactivation of~25-fold (Fig. 4B) . Although these experiments did not clarify whether Ets1 or NFATc was involved at the Ets/NFAT site, the involvement of Ets1 at this site is supported by its unique ability to synergize with AP-1 (see below). GATA-3 gave slightly less transactivation than Ets1 (14-fold) and was consistently more effective than GATA-4 (Fig. 4B) . Our data suggest that GATA-4 can function at the GATA site although less effectively than GATA-3. However, in T h 2 cells, GATA-3 is more likely than GATA-4 to function at the GATA site since it is specifically expressed in these cells.
Synergy of Ets1 with AP-1
Since the Ets and AP-1 binding sites are adjacent in the proximal region of the mouse IL-5 promoter and Ets1 and AP-1 have been reported to form a complex in T lymphocytes (54), 3 . Effect of mutation of transcription factor binding sites on IL-5 induction by activation of MAP kinase pathways. The indicated expression plasmids were co-transfected into D10 cells together with wild-type ÿ1170mIL5Luc or mutated reporter constructs and luciferase activity was determined after stimulation with PMA/cAMP. The mutations carried by the different constructs are indicated and described in detail in Fig. 1(A) . Results represent the average of at least three independent experiments. it was of interest to determine if AP-1 could synergize with Ets1 or any of the other Ets/NFAT family members potentially able to bind to the Ets/NFAT site. Therefore, expression constructs for c-Fos and c-Jun (AP-1) were transiently cotransfected in combination with expression constructs for the other relevant transcription factors into D10 cells. Without stimulation, AP-1 and Ets1 gave strong synergistic transactivation of the ÿ1170mIL5Luc reporter construct elevating expression levels to 10-fold over the additive stimulation of AP-1 and Ets1 alone. Over-expression of the other transcription factors tested, including GATA-3 and GATA-4, did not result in strong synergistic stimulation with AP-1 (Fig. 4C) . The demonstrated strong synergy between AP-1 and Ets1 provides evidence for a role for Ets1 in regulating IL-5 expression at the Ets/NFAT site in T h 2 lymphocytes. Real-time PCR was also used to demonstrate that AP-1/Ets1 transactivation also induced an elevation of IL-5 mRNA levels (Fig. 4D) .
Activation pathways affecting transactivation
The effect of PMA and cAMP, alone and in combination, on transactivation was tested in more detail. In each case, PMA stimulation resulted only in a minor increase in transactivation (Fig. 5) . cAMP was more effective, particularly with AP-1, suggesting that PKA activation is important in AP-1 activation in D10 cells. Strong synergistic stimulation was observed when PMA and cAMP were used together (Fig. 5) . The responses to stimulation by PMA, cAMP or both agents in the transactivation experiments were similar to the responses observed with the ÿ1170mIL5Luc plasmid, although significantly higher values of IL-5 expression were obtained by transactivation. Requirement for the proximal transcription factor binding sites for transactivation A proximal promoter construct (ÿ88mIL5Luc) was used to determine what features of the transactivation observed with the ÿ1170mIL5Luc construct were also observed with the ÿ88mIL5Luc construct. The transactivation results were quite similar to those obtained with the ÿ1170mIL5Luc construct. Dramatic transactivation by AP-1 (430-fold above unstimulated levels) was also observed with the ÿ88mIL5Luc construct in the absence of stimulation and AP-1 and Ets1 gave 3-fold synergistic stimulation (data not shown). These results suggest that the transcription factor binding sites in the proximal promoter region are involved in the transactivations observed. This was verified using derivatives of the ÿ1170mIL5Luc construct carrying mutations at the AP-1, Ets/ NFAT or GATA sites (Fig. 6) . In each case, the transactivation observed with AP-1, Ets1 or GATA-3 was reduced to 1% or less by mutation of the relevant transcription factor binding sites. Significantly, each transactivation was also reduced to a low level by mutating either of the other two binding sites. This indicates that the same mechanism of gene induction is involved in the transactivations observed as in induction by PMA/cAMP and MAP kinase activation. It indicates that each of the three binding sites is obligatorily required for expression of the IL-5 gene and suggests that close cooperation between AP-1, Ets1 and GATA-3 may be involved.
Transactivation by wild type and dominant negative c-Fos and c-Jun
In view of the high levels of transactivation of the ÿ1170mIL5Luc construct achieved with AP-1 (c-Fos/c-Jun), experiments were carried out to determine the level of transactivation by c-Fos and c-Jun alone. Expression constructs were transfected together with ÿ1170mIL5Luc into D10 cells and the cells stimulated with PMA and cAMP. Transactivation by c-Jun was much more effective than by c-Fos but transactivation by a combination of the two was by far the most effective (Fig. 7A) 
Functional independence of the AP-1 and Ets sites
The putative AP-1 and Ets1 sites are adjacent but were shown to be distinct by gel shift experiments. Recombinant AP-1 bound strongly to an oligonucleotide encompassing the AP-1 and Ets/NFAT sites of the promoter. This binding was sequence specific and was abolished by mutation of the AP-1 site but mutation of the Ets site had no effect (Fig. 8B) . The binding of recombinant Ets1 to the oligonucleotide encompassing the AP-1 and Ets sites was much weaker but was sequence specific and was abolished by mutation of the Ets site (Fig. 8B) . Recombinant Ets1 was shown to bind strongly to a consensus oligonucleotide for Ets (Fig. 8B) . Therefore, the failure to demonstrate strong binding with the IL-5 proximal promoter relates to this site and the conditions used and possibly a need for other proteins to be present for optimal binding. AP-1 and Ets1 were also added together but no evidence of the formation of an AP-1-Ets1 complex was obtained (data not shown). The binding of Ets1 to the proximal promoter region was followed up using ChIP assays. Specific binding of Ets1 was shown to be stimulated by PMA/cAMP stimulation (Fig. 8C) . Further confirmation of Ets1 expression in the D10 cells used in these experiments was shown by western blotting (Fig. 8D) . Further support for binding of Ets1 to the Ets/NFAT site in the CLE0 element has come from the previous studies of Thomas et al., (45) who demonstrated binding of Ets1 to the analogous Ets site within the CLE0 element of the granulocyte macrophage colony-stimulating factor promoter using Jurkat nuclear extracts and those of Blumenthal et al., (32) who showed binding of Ets1 to the Fig. 6 . Effect of mutation of the indicated transcription factor binding sites on the transactivation of ÿ1170mIL5Luc by AP-1, Ets1 or GATA-3. After co-transfection of the respective constructs, the D10 cells were stimulated with PMA/cAMP and luciferase activity was measured. The mutations carried by the different constructs are indicated and described in detail in Fig. 1(A) . Results represent the average of at least three independent experiments. identical Ets site in the proximal human IL-5 promoter using recombinant Ets1 produced in insect cells.
Discussion
Antigen-activated T h 2 lymphocytes expressing IL-5 appear to be the primary orchestrators of the eosinophilic inflammation seen in a number of allergic diseases such as asthma. Previous studies have suggested that the IL-5 gene and the other T h 2 cytokine genes are regulated independently in T h 2 lymphocytes (10, 55) despite their apparently coordinate expression in some immune responses. The work described in this paper aimed to increase our understanding of the mechanisms regulating IL-5 expression in T h 2 lymphocytes and used the mouse T h 2 clone D10.G4.1 as a model of normal T cells. In particular, we investigated the significance of an Ets/NFAT site which lies close to the AP-1 site in the proximal promoter region. We established a reporter gene assay in D10 cells and showed that IL-5 transcription could be induced by a combination of PMA/cAMP stimulation and strongly enhanced by specific activation of each MAP kinase pathway. Strong induction of IL-5 mRNA was also achieved by PMA/ cAMP stimulation suggesting that the reporter gene expression was reflecting the expression of the endogenous IL-5 gene.
Mutagenesis showed that the Ets/NFAT site was critical to IL-5 expression in D10 cells and of comparable importance to the AP-1 and GATA sites. Although close to the AP-1 site, mutation of the Ets/NFAT and AP-1 sites showed that they were functionally distinct. Transactivation was used to investigate the activity of different members of the Ets/NFAT family. Ets1 showed a unique ability to strongly synergize with AP-1 suggesting that it has a role in regulating IL-5 expression and that it closely cooperates with AP-1. Real-time PCR showed that AP-1/Ets1 transactivation also induced an elevation of IL-5 mRNA levels. The expression of Ets1 in D10 cells was shown by western blotting. Although Ets1 did not bind strongly in standard gel shift assays, a specific binding of Ets1 to the proximal promoter region which was stimulated by PMA/cAMP was shown by ChIP. It has been shown previously that AP-1 and Ets proteins can physically associate in activated T cells (54) , their interaction mediated through the binding of the basic domain of Jun to the Ets domain of Ets proteins. Jun, in association with Ets, is capable of interacting with Fos family members to form a trimolecular protein complex and the physical association between AP-1 and Ets1 is required for the transcriptional activity of enhancer elements containing adjacent Ets and AP-1 sites (54).
Over-expression of AP-1 alone without other stimulation was extremely effective at switching on IL-5 transcription in D10 cells. Dominant-negative AP-1 constructs showed that AP-1 was involved in normal induction of IL-5 by PMA/cAMP. Previous studies using D10 nuclear extracts have shown that transcription factor binding to the AP-1 site in the CLE0 element is strongly inducible by stimulation (27, 29) and is abolished by inhibition of protein synthesis (27) . Elevation of AP-1 levels when T h 2 lymphocytes are stimulated may therefore be an important part of the process of IL-5 gene induction and may explain our earlier observations that IL-5 transcription in D10 cells induced by a variety of stimulations is strongly dependent on protein synthesis (55, 56) . A key role of AP-1 transcription in regulating human IL-5 induction was also postulated recently (34) .
Two of the stimuli effective in inducing IL-5 expression in D10 cells (cAMP and MAP kinase activation) have been reported to have effects on AP-1, Ets1 or GATA-3 that may be relevant to their action on the IL-5 gene. cAMP stimulation of dopamine b-hydroxylase gene expression is mediated by AP-1 (c-Fos, c-Jun and JunD) with c-Fos transcription being up-regulated by cAMP (58, 59) . cAMP has also been shown to stimulate activation of p38 kinase in D10.G4.1 which can result in increased phosphorylation of GATA-3 and increased expression of IL-5 (21) . In terms of MAP kinase stimulation, ERK has been shown to up-regulate c-Fos, Fra1 and c-Jun expression (60), c-Jun is known to be phosphorylated by JNK (23) and Ets1 can be phosphorylated by ERK (60) . Ras has been shown to activate Ets1 and Ets2 and to induce transcription through an AP-1/Ets composite element (61, 62) . 
